Nerlynx 40 mg – DIN 02490536
Nerlynx is Neratinib Maleate 40 mg (tablet), sold in Canada. It is used for breast cancer. It is supplied by Knight Therapeutics Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Neratinib Maleate 40 mg
- Brand
- Nerlynx
- Strength
- 40 mg
- Used for
- Breast cancer
- Form
- Tablet
- Manufacturer
- Knight Therapeutics Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02490536
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Neratinib used for?
Neratinib is used for breast cancer.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Extended Adjuvant Treatment of Early-Stage Breast Cancer
NERLYNX as a single agent is indicated for the extended adjuvant treatment of adult patients with early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer, to follow adjuvant trastuzumab based therapy.
Advanced or Metastatic Breast Cancer
NERLYNX in combination with capecitabine is indicated for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens in the metastatic setting.
From the FDA-approved label on DailyMed (published Jul 06, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02490536.
- It names Nerlynx, Neratinib Maleate 40 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Nerlynx by Knight Therapeutics Inc..
In Canada: prescription only.
Ingredients
Active: Neratinib (Neratinib Maleate)